Literature DB >> 19354331

Immunologically mediated photodermatoses: diagnosis and treatment.

Thilo Gambichler1, Raida Al-Muhammadi, Stefanie Boms.   

Abstract

Electromagnetic radiation may cause distinct skin conditions. The immunologically mediated photodermatoses (IMP, previous term: idiopathic photodermatoses) represent a heterogenous group of disorders presenting with pathologic skin reactions caused by optical radiation, particularly in the UVA wavelength region. The exact pathomechanism in IMP remains to be elucidated; however, it is very likely (auto)-immunologic in nature. Polymorphic light eruption, actinic prurigo, hydroa vacciniforme, chronic actinic dermatitis, and solar urticaria are the most important conditions that may be summarized under the term IMP. IMP frequently result in a significant reduction in quality of life in affected individuals, mainly because of troublesome symptoms such as intractable itch and pain. Photodiagnostic procedures are mandatory for the exact determination of action spectra and the degree of photosensitivity. Broad-spectrum photoprotection is essential in the prevention of IMP. Photo(chemo)therapeutic regimens are predominantly used to increase the cutaneous immunologic tolerance against ambient UV radiation. In severe forms of IMP, immunomodulatory and immunosuppressive therapies may need to be considered. Overall, IMP form a significant group of skin conditions that can be extremely disabling to the patient and are difficult to diagnose and treat.

Entities:  

Mesh:

Year:  2009        PMID: 19354331     DOI: 10.2165/00128071-200910030-00003

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  3 in total

Review 1.  Photodermatoses: diagnosis and treatment.

Authors:  Percy Lehmann; Thomas Schwarz
Journal:  Dtsch Arztebl Int       Date:  2011-03-04       Impact factor: 5.594

2.  Actinic prurigo of the lip: Two case reports.

Authors:  Ana Mo Miranda; Thiago M Ferrari; Juliana T Werneck; Arley Silva Junior; Karin S Cunha; Eliane P Dias
Journal:  World J Clin Cases       Date:  2014-08-16       Impact factor: 1.337

Review 3.  Ultraviolet A1 Phototherapy for Fibrosing Conditions.

Authors:  Thilo Gambichler; Lutz Schmitz
Journal:  Front Med (Lausanne)       Date:  2018-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.